Isoniazid Hepatotoxicity Associated With Treatment of Latent Tuberculosis Infection

Chest - United States
doi 10.1378/chest.128.1.116
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Treatment of Latent Tuberculosis Infection

Seminars in Respiratory Infections
2003English

Treatment of Latent Infection With Mycobacterium Tuberculosis: Update 2010

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2010English

Poor Compliance Makes Treatment of Latent Tuberculosis Infection Unsatisfactory

Journal of primary care & community health
EnvironmentalPublic HealthHome CareCommunityOccupational Health
2012English

Initial Experience on Rifampin and Pyrazinamide vs Isoniazid in the Treatment of Latent Tuberculosis Infection Among Patients With Silicosis in Hong Kong

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2003English

Treatment Completion for Latent Tuberculosis Infection: A Retrospective Cohort Study Comparing 9 Months of Isoniazid, 4 Months of Rifampin and 3 Months of Isoniazid and Rifapentine

BMC Infectious Diseases
Infectious Diseases
2017English

Benefit of Treatment of Latent Tuberculosis Infection in Individual Patients

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2015English

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis

InPharma
1988English

Barriers to and Motivations for the Implementation of a Treatment Programme for Latent Tuberculosis Infection Using Isoniazid for People Living With HIV, in Upper Northern Thailand

Global journal of health science
Medicine
2013English

Latent Tuberculosis Infection Among University Students

Tuberkulëz i bolezni lëgkikh
PulmonaryInfectious DiseasesRespiratory Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy